ASTRAZENECA HOPEFUL ABOUT RESUMPTION OF U.S. VACCINE TRIALS

Highlights

• Reports state that AstraZeneca is hopeful that the global approval will be determined by results in tests conducted outside the U.S. 

• Human clinical trials in the U.S. were halted by the FDA in early September after a volunteer came down with unex...